Blue Square Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Blue Square Asset Management's AMGN Position: Q3 2026 in Review
Blue Square Asset Management reduced its Amgen (AMGN) stake by 4.5% in Q3 2026, selling an estimated $265K and leaving 14,272 shares worth $6.02M. The position accounts for 2.4% of the portfolio, ranked #16.
Blue Square Asset Management first reported a position in AMGN in Q3 2019 and has held it in 27 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Blue Square Asset Management held 14,272 shares of Amgen worth $6.02M as of Q3 2026.
- Blue Square Asset Management sold 665 Amgen shares in Q3 2026, an estimated $265K.
- Amgen made up 2.4% of Blue Square Asset Management's portfolio in Q3 2026, its #16 holding.
- Blue Square Asset Management first reported a position in Amgen in Q3 2019 and has held it in 27 quarters since.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Blue Square Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.